The first phase of the application of raw white oral liquid in the United States for dietary supplements successfully passed the FDA review

2020-06-24

In order to actively respond to the above-mentioned "One Belt, One Road" development strategy and make practical contributions to the world of traditional Chinese medicine, Mengyang Pharmaceutical actively carried out international project operation in 2017. As an important part of the company's international development, on the basis of years of clinically proven leukocyte/granulocyte active protection and effective immunomodulatory effects, the company's flagship traditional Chinese medicine variety - Shengbai Oral Liquid (overseas trade name LEUCOBOOST) US dietary supplement registration and application work was officially launched at the beginning of this year, the first stage mainly complies with the relevant regulations and guidelines of the US FDA dietary supplements, and the registration and declaration of the technical content such as product functional scope, usage and dosage and label identification. At present, the technical application work at this stage has successfully passed the review of the FDA Food Safety and Applied Nutrition Center (CFSAN), and there is no objection after publicity.

 

 

In the next stage, the company will make every effort to carry out the FDA registration application of the corresponding production facilities, simultaneously accelerate the registration process of raw white oral liquid natural medicine in Canada, and strive to achieve the overseas marketing of the product as soon as possible, fully make up for the clinical defects and deficiencies of similar products with unique clinical characteristics and advantages, and more comprehensively deal with the major clinical problem of bone marrow suppression, so as to provide more adequate and effective treatment options for the majority of patients. At the same time, closely following the theme of integrity, innovation, modernization and internationalization of traditional Chinese medicine, we will vigorously practice and actively respond to the major national policy of inheriting and developing traditional Chinese medicine, and make every effort to promote traditional Chinese medicine to the world.


 

 


Hot news

Service hotline

0724-8886111

Address:3 Fuyao Yi Lu, Doudao District, Jingmen City, Hubei Province, China
Transmissionh:0724-8686500
Email:hbmy_monyan@163.com

COPYRIGHT© 2022 Hubei Mengyang Pharmaceutical Co., LTD. All Rights Reserved E ICP 11014915; Internet Drug Information Service Certificate No. : (E) - Non-business -2016-0032

Technical Support: SUMA